It hasn’t been five minutes into my drive of the 2023 Acura Integra and I’ve yet to take a corner at speed, but I already like this car. The way the steering firms up on the freeway, the adaptive dampers’ ability to smother bumps while contributing to a planted feel, the snick-snick moti
Subscribe to PN+ and watch all episodes commercial free.
Here Phillip Mccluskey from Camloc Motion Control outlines how gas springs should be specified. Part 2 tomorrow.
The primary function of a gas spring is to lift and support an object in a safe and controlled manner. For the designer and end-user of an application, the handling
There’s no arguing about it, Ford has made some great cars over the years. Things like the Escort Mexico, the original Mustang and the F-150 Lightning all showcase the best the Blue Oval can muster.
But with more than 100 years of car-building history under its belt, not everything
This website is using a security service to protect itself from online attacks. The action you just performed triggered the security solution. There are several actions that could trigger this block including submitting a certain word or phrase, a SQL command or malformed data.
You can e
WASHINGTON -- The Padres have played their entire season without Fernando Tatis Jr., eagerly awaiting the return of their superstar shortstop. They will now need to wait until sometime in 2023.
Tatis has been suspended 80 games after testing positive for Clostebol, a performance-enhancin
Having recently sampled the Proton Saga 35th Anniversary Edition, I was humbled at how far our Malaysian “kereta rakyat” has come, 35 years is no easy feat, and it remains as popular as ever.
Just to give you some context, the hallowed BMW 3 Series and Volkswagen Golf namepla
© 2022 MJH Life Sciences and Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
© 2022 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Results from the interim analysis of phase
Cancer cell therapies like Abecma, as well as others that came before it in leukemia and lymphoma, were proven first in patients who had run out of treatment options, usually through clinical trials that lacked a control arm.
Bristol Myers and 2Seventy bio’s study, dubbed KarMMa-3, is